28.1 C
New York
Thursday, July 3, 2025

Tag: runway

ARC RESOURCES LTD. ANNOUNCES THE CLOSING OF ITS MONTNEY ACQUISITION

CALGARY, AB, July 2, 2025 /CNW/ - (TSX: ARX) ARC Resources Ltd. ("ARC" or the "Company") announces that it has closed its previously announced agreement...

From Runway to Radical Reinvention: Sandra Rives Launches “Unapologetically Authentic” Coaching Program for Executive Women

Creator of Red Opium unveils a transformational course helping executive women reclaim confidence, set boundaries, and speak with unapologetic clarity NEW YORK, July 1, 2025...

From Runway to Radical Reinvention: Sandra Rives Launches “Unapologetically Authentic” Coaching Program for Executive Women

Creator of Red Opium unveils a transformational course helping executive women reclaim confidence, set boundaries, and speak with unapologetic clarity NEW YORK, July 1, 2025...

Announcement of fully underwritten rights issue

OSLO, Norway, June 30, 2025 /PRNewswire/ -- BerGenBio ASA the ("Company") hereby announces a fully underwritten rights issue with preferential subscription rights (the "Subscription...

Saudia’s Brand Value Reaches $1.1 Billion with Remarkable 34% Growth

Saudia Airlines has achieved a significant milestone, reaching a brand value of $1.1 billion, a remarkable 34% increase from the previous year.

Seven7 Partners with Altor to Invest in Minority Stake in CCM, the Iconic Global Hockey Brand

STAMFORD, Conn., June 24, 2025 /PRNewswire/ -- Seven7 is pleased to announce its co-investment with leading Nordic private equity firm Altor in the previously announced...

Rockcliffe Capital Initiates Research Coverage on Wheaton Precious Metals Corp. (NYSE/TSX: WPM)

TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- Rockcliffe Capital is pleased to announce today the initiation of equity research coverage on Wheaton Precious Metals Corp. (TSX/NYSE: WPM), the world's premier precious metals streaming company known for its top-tier asset portfolio, strong balance sheet, and robust cash flow generation.

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression

Unlock Your Investment Potential: Why Palantir’s Future is a Golden Opportunity

Hey fabulous finance queens! 🌟 Let's chat about Palantir Technologies, the AI software superstar that's been turning heads and racking up wins in the...

Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock

CYCLACEL PHARMACEUTICALS ANNOUNCES $3 MILLION PRIVATE PLACEMENT OFFERING OF CONVERTIBLE PREFERRED STOCK

BROAD ARROW ADDS THE FOURTH SHELBY COBRA EVER BUILT, CSX 2003, TO MONTEREY JET CENTER AUCTION

REMARKABLY PRESERVED 1962 SHELBY 260 COBRA, ONE OF THE ORIGINAL PROTOTYPE EXAMPLES, OFFERED FROM 36 YEARS OF CHERISHED LONGTERM OWNERSHIP | COBRA JOINED BY MODERN AMERICAN AUTOMOTIVE LEGENDS: HENNESSEY VENOM GT AND THE AMERICAN PERFORMANCE COLLECTION OF DODGE AND CHEVROLET ICONS
REMARKABLY PRESERVED 1962 SHELBY 260 COBRA, ONE OF THE ORIGINAL PROTOTYPE EXAMPLES, OFFERED FROM 36 YEARS OF CHERISHED LONGTERM OWNERSHIP | COBRA JOINED BY MODERN AMERICAN AUTOMOTIVE LEGENDS: HENNESSEY VENOM GT AND THE AMERICAN PERFORMANCE COLLECTION OF DODGE AND CHEVROLET ICONS

Elevation Point Announces Strategic Minority Investment in Family Office Partners, a $2.5 Billion Breakaway Team

UBS Private Wealth Veterans Based in Lafayette, Louisiana Launch Independent Firm Backed by Elevation Point's Growth Partnership Model MINNEAPOLIS, June 20, 2025 /PRNewswire/ -- Elevation Point,...

Azazie Drops Its 2025 Atelier Homecoming Collection — A Whole Fashion Moment for Main Characters Only

LOS ANGELES, June 18, 2025 /PRNewswire/ -- Azazie, the leading DTC e-tailer for all things occasionwear,  announces the launch of its 2025 Atelier Homecoming Collection,...

PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results

PETACH TIKVA, Israel, June 17, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that following its recently announced successful SHIELD II phase 3 topline results, it has secured additional funding through the exercise of warrants with aggregate gross proceeds of $26.7 million. The Company anticipates that with this additional funding, PolyPid’s runway would be extended beyond anticipated FDA approval of D-PLEX₁₀₀.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRunway